Renovaro (RENB) said Tuesday that its BioSymetrics unit received a notice of allowance from the US Patent and Trademark Office for a new patent application.
The patent protects novel methods for integrating and harmonizing diverse biomedical data sources in a framework for predictive modeling, according to Renovaro.
Shares of the company jumped 8.8% in recent trading.
Price: 0.33, Change: +0.04, Percent Change: +14.94
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。